Zolantidine Explained
Zolantidine is a brain-penetrating selective histamine H2 receptor (HRH2) antagonist developed by Smith, Kline & French, with the research code of SK&F 95282. It is a benzothiazole derivative with a 30-fold higher potency for H2 receptors than other peripheral and central receptors.[1]
Notes and References
- Calcutt CR, Ganellin CR, Griffiths R, Leigh BK, Maguire JP, Mitchell RC, Mylek ME, Parsons ME, Smith IR, Young RC . 6 . Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist . British Journal of Pharmacology . 93 . 1 . 69–78 . January 1988 . 2894879 . 1853786 . 10.1111/j.1476-5381.1988.tb11406.x .